Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
January 1, 2019
Patent Application Number
14079901
Date Filed
November 14, 2013
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
